# Subcutaneous Pharmacokinetics of Belatacept

> **NCT00569803** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 153 (actual)

## Conditions studied

- Transplantation

## Interventions

- **DRUG:** belatacept
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00569803
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569803, "Subcutaneous Pharmacokinetics of Belatacept". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00569803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*